India  /  Published 19.09.21

Covaxin: WHO decision in October

The Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organisation would be meeting in October to make its recommendations on Bharat Biotech's Covid-19 vaccine Covaxin...
By Our Bureau, PTI in Hyderabad

India  /  Published 17.09.21

EUL: Covaxin awaits WHO nod

Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine Covaxin to the World health organisation for Emergency Use Listing (EUL) and is awaiting feedback from th...
By Our Bureau, PTI in New Delhi

India  /  Published 09.09.21

CM Covaxin cloud on Rome trip

Mamata Banerjee on Wednesday said she would be unable to travel to Rome to attend an international event on peace next month as she had taken Covaxin, which is yet to get WHO approval for emergency us...
By Our Bureau in Calcutta

India  /  Published 08.09.21

Covaxin supply falls short

Bharat Biotech, the manufacturer of India’s homegrown Covid-19 vaccine, says all is well, but the count of Covaxin doses administered is lower than what the Union health ministry had expected wo...
By G.S. Mudur in New Delhi

India  /  Published 29.08.21

Bharat Biotech scouts partners

Indian vaccine maker Bharat Biotech is seeking international manufacturing partners as it targets a billion doses of its COVID-19 vaccine each year, the company said on Sunday. COVAXIN, the company&#...
By Reuters in New Delhi


India  /  Published 29.08.21

Covaxin response in Covid survivors

A single dose of the homegrown Covaxin in people already infected with Covid-19 is equivalent to two doses in uninfected persons, the country’s health research agency said on Saturday after a pr...
By G.S. Mudur in New Delhi

India  /  Published 28.08.21

Had Covid? Single Covaxin jab works

A single dose of Bharat Biotech's Covaxin in previously COVID-19-infected individuals elicits a similar antibody response as obtained with two doses of the vaccine in those without a previous hist...
By Our Bureau, PTI in New Delhi

India  /  Published 25.08.21

Jabs: Mild side effects for most

Majority of Indians experienced no or only mild side effects after taking two doses of COVID-19 vaccines Covishield and Covaxin, a survey conducted across the country said. A massive COVID-19 vaccina...
By Our Bureau, PTI in New Delhi

India  /  Published 24.08.21

India may enter endemic stage

Covid-19 in India may be entering some kind of stage of endemicity where there is low or moderate level of transmission going on, Chief Scientist of the World Health Organisation Dr Soumya Swaminathan...
By Our Bureau and Agencies in New Delhi

Calcutta  /  Published 24.08.21

Jab recipients in dark on timings

Many Covid vaccination centres of the Calcutta Municipal Corporation did not put up any notice informing people about the changed timings that came into effect on Monday. Many people whose second dos...
By Subhajoy Roy in Calcutta


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.